Europe Pharma 4.0 Market Size & Outlook, 2023-2030

The pharma 4.0 market in Europe is expected to reach a projected revenue of US$ 9,912.5 million by 2030. A compound annual growth rate of 19.2% is expected of Europe pharma 4.0 market from 2024 to 2030.
Revenue, 2023 (US$M)
$2,897.5
Forecast, 2030 (US$M)
$9,912.5
CAGR, 2024 - 2030
19.2%
Report Coverage
Europe

Europe pharma 4.0 market, 2018-2030 (US$M)

Europe
Unlock Premium

Europe pharma 4.0 market highlights

  • The Europe pharma 4.0 market generated a revenue of USD 2,897.5 million in 2023.
  • The market is expected to grow at a CAGR of 19.2% from 2024 to 2030.
  • In terms of segment, software was the largest revenue generating type in 2023.
  • Software is the most lucrative type segment registering the fastest growth during the forecast period.


Europe data book summary

Market revenue in 2023USD 2,897.5 million
Market revenue in 2030USD 9,912.5 million
Growth rate19.2% (CAGR from 2023 to 2030)
Largest segmentSoftware
Fastest growing segmentSoftware
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSoftware
Key market players worldwideMicrosoft Corp, International Business Machines Corp, Amazon Web Services, SAP SE, Oracle Corp, GE Healthcare, Siemens Healthineers AG ADR, Cisco Systems Inc, Cinntra Infotech, Dassault Systemes SE, nexocode


Other key industry trends

  • In terms of revenue, Europe region accounted for 27.1% of the global pharma 4.0 market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 8,481.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Pharma 4.0 Market Scope

Pharma 4.0 market segmentation & scope
Software
Services
Technology
AI &ML
Big Data Analytics
IoT
Blockchain Technology
Other
Application
Drug Discovery & Development
Manufacturing
Supply Chain Management
Others
End Use
Pharma & Biotech companies
Healthcare Providers
CMO (Contract Manufacturing Organization)
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
China
Japan
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Pharma 4.0 Market Companies

Name Profile # Employees HQ Website

Europe pharma 4.0 market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharma 4.0 market will help companies and investors design strategic landscapes.


Software was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe pharma 4.0 market based on software covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe pharma 4.0 market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe pharma 4.0 market databook

  • Our clientele includes a mix of pharma 4.0 market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pharma 4.0 market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pharma 4.0 market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe pharma 4.0 market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more